Hyperfibrinolysis associated with plasmin leads to elevated D-dimer concentrations in severe patients; hence, the authors suggest that plasmin(ogen) may prove to be a promising therapeutic target for combating COVID-19 [210]. This evidence concerns the gene PLG and COVID-19.